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Abstract
Purpose: Image quality of positron emission tomography (PET) tracers that emits high-energy
positrons, such as Ga-68, Rb-82, or I-124, is significantly affected by positron range (PR)
effects. PR effects are especially important in small animal PET studies, since they can limit
spatial resolution and quantitative accuracy of the images. Since generators accessibility has
made Ga-68 tracers wide available, the aim of this study is to show how the quantitative results
of [68Ga]DOTA-labeled PET/X-ray computed tomography (CT) imaging of neuroendocrine
tumors in mice can be improved using positron range correction (PRC).
Procedures: Eighteen scans in 12 mice were evaluated, with three different models of tumors:
PC12, AR42J, and meningiomas. In addition, three different [68Ga]DOTA-labeled radiotracers
were used to evaluate the PRC with different tracer distributions: [68Ga]DOTANOC,
[68Ga]DOTATOC, and [68Ga]DOTATATE. Two PRC methods were evaluated: a tissue-
dependent (TD-PRC) and a tissue-dependent spatially-variant correction (TDSV-PRC). Taking
a region in the liver as reference, the tissue-to-liver ratio values for tumor tissue (TLRtumor), lung
(TLRlung), and necrotic areas within the tumors (TLRnecrotic) and their respective relative
variations (ΔTLR) were evaluated.
Results: All TLR values in the PRC images were significantly different (p G 0.05) than the ones
from non-PRC images. The relative differences of the tumor TLR values, respect to the case
with no PRC, were ΔTLRtumor 87 ± 41 % (TD-PRC) and 85 ± 46 % (TDSV-PRC). TLRlung
decreased when applying PRC, being this effect more remarkable for the TDSV-PRC method,
with relative differences respect to no PRC: ΔTLRlung = − 45 ± 24 (TD-PRC), − 55 ± 18 (TDSV-
PRC). TLRnecrotic values also
decreased when using PRC,
with more noticeable differ-
e n c e s f o r T D - P R C :
ΔTLRnecrotic = − 52 ± 6 (TD-
PRC), − 48 ± 8 (TDSV-PRC).
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Conclusion: The PRC methods proposed provide a significant quantitative improvement in
[68Ga]DOTA-labeled PET/CT imaging of mice with neuroendocrine tumors, hence demonstrat-
ing that these techniques could also ameliorate the deleterious effect of the positron range in
clinical PET imaging.
Key words: [68Ga]DOTA-labeled radiotracers, Positron range correction, Small animal PET/CT,
PET image reconstruction
Introduction
With the extension of the positron emission tomography
(PET) from clinical to preclinical research, it is possible to
obtain preclinical PET images with sub-millimeter resolution
and sensitivity close to 10 % [1]. Apart from the PET
radionuclides more conventionally used such as F-18, C-11,
and N-13, other radionuclides such as Ga-68, I-124, and Rb-
82 have been proposed for PET imaging, with hundreds of
PET radiotracers based on these radionuclides being devel-
oped [2].
[68Ga]DOTA-labeled somatostatin analogues bind specifi-
cally to somatostatin receptors (SSTRs) and are commonly used
for imaging and treatment planning of neuroendocrine tumors
(NETs) [3–8]. Moreover, [68Ga]DOTA-labeled somatostatin
analogues have been reported to show higher sensitivity for the
detection of NETs and other somatostatin-receptor expressing
tumors than the most widely used radiotracer, 2-deoxy-2-
[18F]fluoro-D-glucose ([18F]FDG), which is used to measure
glucose metabolism [9–11]. This makes them ideally suited for
this kind of tumors, which due to the availability of Ga-68
generators explain the wide spreading use of the these
radionuclides during the last years.
However, obtaining accurate quantification and in general
good quality images from Ga-68 PET is a challenging task
[12–15]. The main concern lies with the high-energy
positrons emitted by this radionuclide (see Table 1), which
result in significant positron range (PR) effects affecting the
spatial resolution of the PET images. PR effects are even
more pronounced in high-resolution preclinical PET systems
[18]. Figure 1 illustrates the degraded image quality due to
the positron range effect when imaging Ga-68 based
radiotracers. The figure shows simulated PET images of a
NEMA NU4 image quality phantom [19] filled with
respectively F-18 and Ga-68. As expected, a significant
degradation of the quality of the images obtained with Ga-68
is observed, with lower spatial resolution and contrast, due
to the larger positron range of the Ga-68 radionuclide.
Therefore, an accurate correction of the PR effects is
necessary to obtain good quantification for small animal
images with Ga-68 radiotracers.
Indeed, the blurring effect of the PR may be described as
a contribution to the system point spread function (PSF) [21,
22]. Several methodologies have been proposed to model PR
effects during reconstruction. In a homogeneous medium,
for example, this blurring can be considered as isotropic [23,
24] with a non-Gaussian shape with a sharp central cusp and
relatively broad tails. Therefore, most correction techniques
for PR make use of analytic space-invariant isotropic
blurring kernels. This is computationally very efficient but
it is only valid for cases where tracer uptake is surrounded
by a homogeneous medium [22, 25, 26]. To address
inhomogeneous media, space variant analytic kernels have
been proposed [27–29]. However, this remains challenging
due to the complexity and irregularity of tissue boundaries.
An alternative approach to analytic models is the use of on-
the-fly Monte Carlo (MC) simulations to model the
interactions of positrons at tissue boundaries such as lung/
soft tissue and soft tissue/bone interfaces [30], which can be
extracted from X-ray computed tomography (CT) or
magnetic resonance (MR) scans. In this process, the local
tissue delineation can be considered and appropriate blurring
kernels can be generated for each individual voxel.
In a previous work [31], we proposed a fully tissue-
dependent and spatially variant positron range correction
(PRC) method which uses analytical expressions for the PR
blurring kernels, obtained from fits to Monte Carlo simula-
tions [24]. The procedure takes into account the different
materials that the positron travels by until it annihilates. This
information is taken from co-registered CT images. The
simulations and phantom experiments performed in [31]
demonstrated that the proposed PRC yields artifact-free
images with up to a factor two resolution recovery for
medium-large positron range radionuclides like 68Ga.
The aim of this work is to evaluate the previously
developed PRC method in [68Ga]DOTA-labeled PET/CT
Table 1.. Properties of the Ga-68 positron emitter, compared with the standard F-18. The half-life, mean, and maximum energies of the emitted positron
(Eβmean, Eβmax) have been obtained from [16], while the mean and maximum positron range values in water (Rmean, Rmax) were obtained from [17]
Radionuclide Half-life (min) Eβmean (keV) Eβmax (keV) Rmean—water (mm) Rmax—water (mm)
F-18 109.8 250 634 0.6 2.4
Ga-68 67.7 836 1899 2.9 8.2
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images of mice with neuroendocrine tumors and to show
how the quantification of this highly demanding application
can be improved by using the proposed PRC.
Materials and Methods
Animals
The experiments were performed using 12 male NUDE NU/
NU mice. Animals were purchased from Charles River
Laboratories (Spain), maintained at a constant temperature
(24 ± 0.5 °C) under a 12-h light/dark cycle, and permitted
access to commercial rodent laboratory chow and water ad
libitum. All animal procedures were approved by the Animal
Experimentation Ethics Committee of Hospital General
Universitario Gregorio Marañón, Madrid, Spain, and were
performed according to EU directive 2010/63/EU and
national regulations (RD 53/2013).
Details about the cell culture, xenotransplantation, and
the synthesis of the [68Ga]DOTA-peptides are available in
the Electronic Supplementary Material (ESM).
Data Acquisition
Data were acquired with a high-resolution small-animal
ARGUS PET-CT scanner (Sedecal, Spain) [32]. This
tomograph has a transaxial and axial FOV of 68 and
48 mm respectively, and it is able of sub-millimetric
resolution using iterative (PET) or direct 3D reconstruction
(CT) [33, 34].
We evaluated 18 PET/CT scans. Imaging was performed
between 7 and 53 days after tumor cell inoculation. Three different
68Ga-based tracers were used in this work: [68Ga]DOTATOC,
[68Ga]DOTANOC, and [68Ga]DOTATATE. The tumor models
and tracers were chosen to explore the performance of the
proposed PRC method in a wide variety of cases with different
tracer distributions.
Fig. 1 The positron range effect when imaging a NEMA NU 4 image quality phantom [19] filled with Ga-68. In the top row of
the figure, we show a schematic view of the a upper and b lower (right) parts of the phantom. c In the center row, we show
transaxial views centered in these two parts, in simulated PET acquisitions of the phantom filled with F-18 and with Ga-68 and
reconstructed with an standard OSEM algorithm without PRC. The differences in spatial resolution and contrast between the F-
18 and Ga-68 images are due to the larger positron range of the Ga-68 radionuclide. d Finally, in the bottom row, we show the
same images of the phantom, reconstructed with a tissue-dependent positron range correction (TD-PRC). For more details, we
refer the reader to [20].
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Further details about the mice scans and the data
acquisition (Suppl. Table 1) and reconstruction are provided
in ESM.
Positron Range Correction
Two methods for PRC were evaluated in this work: a tissue-
dependent (TD-PRC) and a tissue-dependent spatially-
variant correction (TDSV-PRC). The PR blurring kernel is
employed during the forward projection step in the iterative
reconstruction procedure, as illustrated in Fig. 2. Details
about the PRC methodology are provided in ESM.
Experimental Data Analysis
A reference region was located inside the liver of the mouse,
defined as a cylinder of 3-mm diameter by 3-mm height. We
evaluated the tissue-to-reference ratio values for several
volumes of interest (VOIs): tumor tissue (TLRtumor), lung
(TLRlung), and necrotic areas (TLRnecrotic), if the tumor
presented a necrotic area with reduced uptake of the tracer.
The segmentation of the tumor volume was performed from
the PET images by drawing the 3D isocontour at 50 % of the
maximum voxel value, measured from the TDSV-PRC PET
images. The VOIs in lung and necrotic areas were defined as
cylinders with the same size than the liver VOI. Figure 3
shows an example of the defined VOIs evaluated in this
work, for a mouse with a tumor in which no necrotic area
was observed (Fig. 3a) and for another mouse with necrotic
area (Fig. 3b). All reconstructed images were evaluated at
the same noise level. As the convergence speed of the
OSEM algorithm with and without PRC is different, to
ensure equal noise levels, the number of image updates in
the reconstructed images used for the comparisons was
higher in the non-PRC images than in the PRC images (see
[20] and Table 2 for details).
To evaluate the effect of PRC methods on the quantifi-
cation of the PET images, we calculated the relative changes
in the evaluated tissue-to-background ratios (ΔTLR) after
applying PRC. The ΔTLR was calculated as follows:
ΔTLR %ð Þ ¼ TLR PRCð Þ−TLR noPRCð Þ
TLR noPRCð Þ ∙100 ð1Þ
where TLR(PRC) is the tissue-to-background ratio after
applying the PRC and TLR(noPRC) is the tissue-to-liver
ratio measured in the image reconstructed without any PRC.
All TLR, noise, and ΔTLR values were reported as mean
± standard deviation (SD). One-way ANOVA and the
Bonferroni test for means comparison were used to evaluate
statistical significant changes in the TLR or noise values
obtained without PRC, with TD-PRC, and with TDSV-PRC.
Results
Figure 4 shows the Ga-68 PET/CT images without PRC
(left) and with TD (center) and TDSV (right) PRC of mice
with implanted PC12, AR42J, and meningioma tumor
models. The visual inspection of the images reveals a
significant increase of the contrast of the images after
applying PRC. Furthermore, a significant increase of the
tracer uptake in the tumor is observed in all cases.
Alternatively, Fig. 5 shows scans of the same mouse done
at different stages of the tumor growth (7, 13, and 20 days
after inoculation of meningioma tumor cells), with and
without PRC. It is clear that at early stages (7 days), the
small size of the tumor does not allow to see increased tumor
uptake in the standard non-PRC reconstruction, while when
PRC is incorporated into the reconstruction algorithm, a
significant increase of tumor uptake can be observed. In later
stages (13 and 20 days), necrotic areas appear within the
tumors, and a significant improvement of the contrast in this
area is appreciated when PRC is applied.
Table 2 shows mean, SD, and maximum and minimum
values for TLR obtained for each of the VOIs evaluated.
The table also presents mean noise values and number of
Fig. 2 The PRC method used in this work. The PR blurring kernel is modeled with Monte Carlo simulations and introduced into
the reconstruction algorithm as an additional blurring to the image before the projection step in each iteration (1), (2), (3), etc. of
the reconstruction algorithm.
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iterations of the reconstructed image used for the
evaluations. As mentioned above, due to the fact that
PRC methods tend to increase the noise in the recon-
structed images, we compared reconstructions at different
number of iterations, with the aim of evaluating the
different methods at the same noise level. Table 3 shows
the mean and SD ΔTLR values for TD and TDSV PRC
in all the VOIs evaluated and the P values obtained from
the Bonferroni test. The mean ± SD relative change in
noise and the correspondent P values are also shown in
Table 3. With TD-PRC, we observed a mean increase of
TLRtumor values of 87 ± 41 %, while with TDSV-PRC, it
was 85 ± 46 %. TLRlung in general decreased when
applying PRC, with more significant decreases with
TDSV-PRC: mean ΔTLRlung = − 55 ± 18 %. TLRnecrotic
values also decreased when using PRC, but in this case,
the difference is more noticeable for the TD-PRC: mean
ΔTLRnecrotic = − 52 ± 6 %. The contrast improvement of
the images reconstructed with PRC is further demon-
strated in Fig. 6, which presents box chart plots for
TLRtumor, TLRlung, and TLRnecrotic, obtained from images
reconstructed without PRC (No PRC), with tissue-
dependent PRC (TD-PRC), and with tissue-dependent
spatially-variant PRC (TDSV-PRC).
Discussion
In this work, we evaluated two different PRC methods in
[68Ga]DOTA-labeled PET/CT imaging of mice with im-
planted neuroendocrine tumors: a tissue-dependent correc-
tion (TD-PRC), which uses an isotropic spatially-invariant
blurring kernel, and a tissue-dependent spatially-variant
correction (TDSV-PRC), in which the different materials
that the positron travels by until it annihilates are taken into
account. Eighteen independent scans in 12 mice were
evaluated, with three models of tumors and three
[68Ga]DOTA-labeled radiotracers, in order to evaluate the
PRC performance in cases with different tracer distributions.
As expected, the relatively large PR of the Ga-68
radionuclide results in PET images with a significant
reduced image quality, as illustrated in the example
presented at Fig. 1. When using any of the proposed
methods for PRC, we observed a noticeable improvement
in the contrast of the reconstructed PET images (see Figs. 4,
5, and 6 and Tables 2 and 3) in all the cases.
In general, TDSV-PRC provides better results than
TD-PRC. Although the TLRtumor (TLRnecrotic) values
obtained with the TD-PRC are slightly higher (lower)
than the ones obtained with TDSV-PRC; these differ-
ences are very small, not statistically significant at a
Fig. 3 Coronal views of the combined PET (color) and CT (gray scale) mice images. VOIs evaluated in this work, for a mouse
with a tumor in which a no necrotic area was observed and b for a mouse with necrotic area. All the VOIs depicted in lung, liver,
and necrotic areas were cylinders. The tumor VOIs were generated by using a threshold-based method to the 50 % of the
maximum voxel value, measured from the PRC PET images.
Table 2.. Mean, SD, and maximum and minimum values for the TLR obtained in each VOIs. Bottom row: mean noise values and mean number of image
updates of the reconstructed image used for the evaluations. Due to the different convergence properties of the PRC and no-PRC reconstruction algorithms, we
aimed to compare images at the same level of noise, and in consequence, with different number of image updates in the iterative algorithms [20, 31]
N total No PRC TD-PRC TDSV-PRC
Mean ± SD Range Mean ± SD Range Mean ± SD Range
TLRtumor 22 1.6 ± 0.6 0.88–3.35 3.0 ± 1.4 1.40–6.57 3.0 ± 1.7 1.34–7.54
TLRlung 18 0.62 ± 0.22 0.21–1.02 0.36 ± 0.21 0.04–0.75 0.29 ± 0.17 0.05–0.58
TLRnecrotic 7 0.46 ± 0.16 0.29–0.78 0.22 ± 0.08 0.13–0.39 0.24 ± 0.09 0.13–0.41
Noise (%) 18 14.9 ± 3.8 11.5–28.0 14.7 ± 4.3 10.3–29.3 14.8 ± 4.3 10.4–29.1
(#Image updates) 150 to 200 100 100
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confidence level of 5 %, as shown in Table 3. However,
a noticeable smaller TLRlung was obtained with TDSV-
PRC. In addition, artificially increased uptakes at the
edges of the animal bodies were observed when using
the TD-PRC, due to the wrong blurring kernels used by
this method at these regions, namely, homogeneous
kernels using tissue as reference in voxels within the
body, when inhomogeneous kernels accounting for the
boundary tissue-air should be used.
A general limitation of the proposed PRC methods is the
increase of noise in the image due to the positron range
blurring kernel deconvolution being applied only in the
Fig. 4 [68Ga]DOTA-labeled PET/CT images without (left), with TD (center), and with TDSV (right) PRC of mice with implanted
PC12, AR42J, and meningioma tumor cells. White arrows point to tumor regions with increased tracer uptake, while red arrows
(top) point to necrotic areas in the tumor, with reduced tracer uptake. The yellow arrows on the bottom point to an artifact in
which the heart uptake is wrongly co-registered with heart tissue (TD-PRC image). This is due to an over correction of the PR
effect in the voxels close to the heart, where there is lung tissue, and therefore, a kernel blurring corresponding to lung is used
in the TD-PRC, but the lung-heart boundary significant reduces the PR kernel in this direction. When the TDSV-PRC is used,
the heart uptake is correctly co-registered with heart tissue. Note that the tumor with necrotic area (PC12) corresponds to
mouse 3, which was scanned 53 days after inoculation of the tumor cells.
Fig. 5 Scans of the same mouse, performed at different stages of the tumor growth: 7, 13, and 20 days after the inoculation of
meningioma tumor cells. The PET images were reconstructed without (left), with TD (center), and with TDSV (right) PRC. White
arrows point to active areas of the tumors, with increased [68Ga]DOTATATE uptake, while red arrows point to necrotic areas of
the tumors.
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forward projection [28]. In this work, we have taken this
issue into account by evaluating PRC and no-PRC images
reconstructed at different number of image updates, in order
to obtain similar noise values in both PRC and no-PRC
Table 3.. Mean, SD, and (minimum, maximum) values for the ΔTLR obtained in each evaluated VOIs. Bottom row: mean, SD, and (minimum, maximum)
Δnoise values. The P values for the statistically different means (Bonferroni test, 5 % confidence level) are also shown in the table. NS not significant
statistical differences
N total TD - PRC TDSV - PRC
Mean ± SD Range P (No PRC) Mean ± SD Range P (No PRC) P (TD-PRC)
ΔTLRtumor (%) 22 87 ± 41 (37, 195) 0.003 85 ± 46 (31, 208) 0.002 NS
ΔTLRlung (%) 18 − 45 ± 24 (− 81, 0) G 0.001 − 55 ± 18 (− 78, − 16) G 0.001 NS
ΔTLRnecrotic (%) 7 − 52 ± 6 (− 61, −44) 0.004 − 48 ± 8 (− 61, − 40) 0.007 NS
ΔNoise (%) 18 − 0.8 ± 3.0 (− 7, 5) NS 0.4 ± 3.7 (− 6, 7) NS NS
Fig. 6 a TLRtumor, b TLRlung, c TLRnecrotic, and d noise values obtained from the images reconstructed without PRC (No PRC),
with TD PRC, and with TDSV-PRC. NS not significant statistical differences in the means (Bonferroni test, 5 % confidence
level). *Statistically significant differences at 5 % confidence level (0.05 9 P 9 0.001). **Statistically significant differences at
0.1 % confidence level (P G 0.001).
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images (see Table 3). Several approaches to overcome the
noise limitation of PRC methods have been evaluated in the
literature, such as using a maximum-a-posteriori (MAP)
regularization in the image reconstruction process [26, 28] or
introducing the positron range blurring kernel also in the
back-projection step. This additional step leads to slower
convergence of the reconstruction algorithm, as discussed in
[20]. Although it is known that the mismatch between
forward and backward projectors can exhibit problems in
some cases [35], in general, using a less accurate backward
projector is safe, provided that the forward projector
contains all the relevant blurring effects, as discussed in
[36, 37]. In our case, if PR is modeled also in the back-
projection stage, we find essentially the same images, but the
reconstruction process needs more number of iterations and
takes longer. A full evaluation of the performance of the
reconstruction algorithm with TDSV-PRC in both forward
and backward projectors is out of the scope of this paper and
it is going to be performed in future work.
As discussed in [31], the computation of the TDSV
blurring kernel adds a manageable overhead to the overall
reconstruction time, comparing with the TD correction.
However, even for large-range isotopes, the computation
time must not be considered as a limitation for preclinical
applications. In the [68Ga]DOTA-labeled studies considered
in this work, the TDSV-PRC OSEM reconstruction using
two iterations and 50 subsets took about 60 min in a single-
core Intel Xeon @ 3.0 GHz. By using an open-MP parallel
implementation of the code in eight cores this time can be
reduced up to less than 10 min. This computation time is
faster than other proposed PRC methods based on on-the-fly
Monte Carlo estimations of positron range, since even if the
PRC is applied as a residual correction after a given number
of image updates, like in [30], at least one full Monte Carlo
simulation is needed during the reconstruction process,
which is more computationally demanding than our calcu-
lation of the TDSV blurring, which is performed only once
at the beginning of the reconstruction.
Implications of This Work and Future Research
The results presented in this paper, together with the
validations presented in [31], demonstrate that the quantita-
tive evaluation of small animal PET images obtained with
68Ga-DOTA-labeled radiotracers is improved when using
appropriate PRC. This improved quantification can increase
the diagnostic value of 68Ga radiotracers, already established
or under development [5, 38–40]. This would also apply to
any preclinical study performed using radiotracers based on
medium-large positron range radionuclides, such as O-15,
I-124, or Rb-82 [41–44].
Although the most critical image degradation of the PET
images due to positron range is seen in high-resolution
small-animal imaging, this effect can also be relevant in
clinical PET studies. For example, it is known that
myocardial perfusion studies with 82Rb suffer from signif-
icant resolution degradation mainly due to the large PR of
Rb-82 (5.9 mm [17]). Only a few works have tried to
improve the quantitative properties of this kind of studies by
means of PRC [26, 27, 45]. Alternatively, Abdul-Fatah and
colleagues [46] identified shine-trough artifacts when imag-
ing thyroid tumors in the trachea with I-124 PET/CT due to
its large PR. This effect may be even more important in
PET/MR, when the high magnetic field in the axial axis
creates an elongation of the PR in that direction [47, 48], as
recently discussed by Kolb and colleagues [49]. To the best
of our knowledge, these issues are still not solved. The
implementation of our TDSV-PRC method in clinical PET/
MR systems by means of an accurate 3D modeling of the PR
kernel in magnetic fields is work in progress.
Conclusion
The proposed PRC methods provide high-resolution PET
images with a significant quantitative improvement in
[68Ga]DOTA-labeled PET/CT imaging of mice with neuro-
endocrine tumors. Furthermore, the TDSV-PRC method
results in accurate images free of artifacts in the tissue
boundaries and with better contrast than the more simplistic
TD-PRC. The results presented in this paper reveal a
significant importance of performing an accurate PRC for
the quantitative evaluation of small animal PET images
obtained with medium-large positron range radionuclides.
Clinical studies with large-range nuclides (cardiac Rb-82) or
cases in which the lesion of interest is close to a tissue
boundary (thyroid tumors) would also benefit of TDSV-
PRC.
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